European Medicines Agency starts review of ibuprofen medicines (23.06.2014)
PRAC recommends against combined use of medicines affecting the renin-angiotensin (RAS) system (24.04.2014)
European Medicines Agency concludes class review of bisphosphonates and atypical fractures
Benefit-risk review of Multaq started
European Medicines Agency recommends use of fibrates as second-line treatment
